Salts and Solid Forms of (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-Oxoisoindolin-2-YL)PIPERIDINE-2,6-Dione and Compositions Comprising and Methods of Using the Same
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 61/681,484, filed Aug 9, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,629,849 | Salts and Solid Forms of (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-Oxoisoindolin-2-YL)PIPERIDINE-2,6-Dione and Compositions Comprising and Methods of Using the Same In force · Medium confidence | Celgene Corporation | In force | Medium confidence | ||
| US 9,884,062 | Salts and Solid Forms of (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-Oxoisoindolin-2-YL)PIPERIDINE-2,6-Dione and Compositions Comprising and Methods of Using the Same In force · Medium confidence | Celgene Corporation | In force | Medium confidence | ||
| US 10,463,672 | Salts and Solid Forms of (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-Oxoisoindolin-2-YL)PIPERIDINE-2,6-Dione and Compositions Comprising and Methods of Using the Same In force · Medium confidence | Celgene Corporation | In force | Medium confidence | ||
| US 10,596,180 | Salts and Solid Forms of (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-Oxoisoindolin-2-YL)PIPERIDINE-2,6-Dione and Compositions Comprising and Methods of Using the Same In force · Low confidence | Celgene Corporation | In force | Low confidence | ||
| US 12,343,346 | Salts and Solid Forms of (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-Oxoisoindolin-2-YL)PIPERIDINE-2,6-Dione and Compositions Comprising and Methods of Using the Same In force · Medium confidence | Celgene Corporation | In force | Medium confidence | ||
| US 9,221,788 | Salts and Solid Forms of (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-Oxoisoindolin-2-YL)PIPERIDINE-2,6-Dione and Compositions Comprising and Methods of Using the Same In force · High confidence | Celgene Corporation | In force | High confidence | ||
| US 11,241,439 | Salts and Solid Forms of (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-Oxoisoindolin-2-YL)PIPERIDINE-2,6-Dione and Compositions Comprising and Methods of Using the Same In force · Medium confidence | Celgene Corporation | In force | Medium confidence | ||
| Application 17/570,299 | Salts and Solid Forms of (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-Oxoisoindolin-2-YL)PIPERIDINE-2,6-Dione and Compositions Comprising and Methods of Using the Same Abandoned Abandoned Aug 9, 2024 | Celgene Corporation | Abandoned | Abandoned Aug 9, 2024 | ||
| Application 19/217,914 | Salts and Solid Forms of (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-Oxoisoindolin-2-YL)PIPERIDINE-2,6-Dione and Compositions Comprising and Methods of Using the Same Pending Not granted | Celgene Corporation | Pending | Not granted |
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
7 of these are in force and held by Celgene Corporation.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.